Organic anion transporter 4 (OAT 4) modifies placental transfer of perfluorinated alkyl acids PFOS and PFOA in human placental ex vivo perfusion system

Placenta

Volumn 36, Issue 10, 2015, Pages 1185-1191

  Kummu, M ^a   Sieppi, E ^a   Koponen, J ^d   Laatio, L ^b   Vahakangas K ^c   Kiviranta, H ^d   Rautio, A ^a   Myllynen, P ^a,e  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e Nordlab Oulu   (Finland)

Author keywords

ABCG2; Fetal exposure; OAT4; Perfluoro octane sulphonate; Perfluoro octanoate; PFAA

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER 4; PERFLUORO COMPOUND; PERFLUORO OCTANE SULPHONATE; PERFLUORO OCTANOATE; PHENAZONE; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; ORGANIC ANION TRANSPORTER; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; SLC22A11 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EX VIVO STUDY; FEMALE; FETUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VIVO STUDY; NORMAL HUMAN; PLACENTA PERFUSION; PLACENTAL TRANSFER; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; FETOMATERNAL TRANSFUSION; IN VITRO STUDY; METABOLISM; PLACENTA; PREGNANCY;

ALKANESULFONIC ACIDS; ATP-BINDING CASSETTE TRANSPORTERS; CAPRYLATES; FEMALE; FLUOROCARBONS; HUMANS; IN VITRO TECHNIQUES; MATERNAL-FETAL EXCHANGE; NEOPLASM PROTEINS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; PLACENTA; PREGNANCY;

EID: 84944188905     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2015.07.119     Document Type: Article

References (36)

1. J.P. Giesy, and K. Kannan Global distribution of perfluorooctane sulfonate in wildlife Environ. Sci. Technol. 35 7 Apr. 2001 1339 1342
2. H. Bjermo, P.O. Darnerud, M. Pearson, H.E. Barbieri, A.K. Lindroos, C. Nälsén, C.H. Lindh, B. a G. Jönsson, and A. Glynn Serum concentrations of perfluorinated alkyl acids and their associations with diet and personal characteristics among Swedish adults Mol. Nutr. Food Res. Aug. 2013 1 10
3. H. Fromme, S. a Tittlemier, W. Völkel, M. Wilhelm, and D. Twardella Perfluorinated compounds-exposure assessment for the general population in Western countries Int. J. Hyg. Environ. Health 212 3 May 2009 239 270
4. D.A. Savitz, C.R. Stein, B. Elston, G.A. Wellenius, S.M. Bartell, H. Shin, V.M. Vieira, and T. Fletcher Research | Children's health relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the Mid-Ohio valley 120 8 2012 1201 1207
5. A. Vested, C.H. Ramlau-hansen, S.F. Olsen, J.P. Bonde, and S.L. Kristensen Associations of in utero exposure to perfluorinated alkyl acids with human 121 4 2013 453 458
6. C.R. Stein, M.S. Wolff, A.M. Calafat, K. Kato, and S.M. Engel Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a pilot study Reprod. Toxicol. 34 3 2012 312 316
7. C. Prouillac, and S. Lecoeur The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies 38 10 2010 1623 1635
8. S. Ekaratanawong, N. Anzai, P. Jutabha, H. Miyazaki, and R. Noshiro full paper human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules 304 2004 297 304
9. B. Ugele, M.V. St-Pierre, M. Pihusch, A. Bahn, and P. Hantschmann Characterization and identification of steroid sulfate transporters of human placenta Am. J. Physiol. Endocrinol. Metab. 284 2 Feb. 2003 E390 E398
10. K. Vähäkangas, and P. Myllynen Drug transporters in the human blood-placental barrier Br. J. Pharmacol. 158 3 Oct. 2009 665 678
11. Y.M. Weaver, D.J. Ehresman, J.L. Butenhoff, and B. Hagenbuch Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths Toxicol. Sci. 113 2 Feb. 2010 305 314
12. H. Nakagawa, T. Terada, K.H. Harada, T. Hitomi, K. Inoue, K.-I. Inui, and A. Koizumi Human organic anion transporter hOAT4 is a transporter of perfluorooctanoic acid Basic Clin. Pharmacol. Toxicol. 105 2 Aug. 2009 136 138
13. N. Kudo, M. Katakura, Y. Sato, and Y. Kawashima Sex hormone-regulated renal transport of perfluorooctanoic acid Chem. Biol. Interact. 139 3 Mar. 2002 301 316
14. E. Immonen, M. Kummu, a Petsalo, T. Pihlaja, L. Mathiesen, J.K.S. Nielsen, L.E. Knudsen, K. Vähäkangas, and P. Myllynen Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic metabolism Placenta 31 7 Jul. 2010 641 648
15. P. Myllynen, M. Kummu, T. Kangas, M. Ilves, E. Immonen, J. Rysä, R. Pirilä, A. Lastumäki, and K.H. Vähäkangas ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta Toxicol. Appl. Pharmacol. 232 2 Oct. 2008 210 217
16. a. L. Brantsæter, K.W. Whitworth, T. a. Ydersbond, L.S. Haug, M. Haugen, H.K. Knutsen, C. Thomsen, H.M. Meltzer, G. Becher, a. Sabaredzovic, J. a. Hoppin, M. Eggesbø, and M.P. Longnecker Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women Environ. Int. 54 2013 74 84
17. K. Vorkamp, F. Nielsen, H.B. Kyhl, S. Husby, L.B. Nielsen, T. Barington, A.M. Andersson, and T.K. Jensen Polybrominated diphenyl ethers and perfluoroalkyl substances in serum of pregnant women: levels, correlations, and potential health implications Arch. Environ. Contam. Toxicol. 67 2014 9 20
18. G.W. Olsen, K.J. Hansen, L. a Stevenson, J.M. Burris, and J.H. Mandel Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals Environ. Sci. Technol. 37 5 Mar. 2003 888 891
19. L.A. Darrow, C.R. Stein, and K. Steenland Research|children's health serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio valley, 2005 - 2010 121 10 2013 2005 2010
20. J. Koponen, P. Rantakokko, R. Airaksinen, and H. Kiviranta Determination of selected perfluorinated alkyl acids and persistent organic pollutants from a small volume human serum sample relevant for epidemiological studies J. Chromatogr. A 1309 Sep. 2013 48 55
21. M. Kummu, E. Sieppi, K. Wallin, a Rautio, K. Vähäkangas, and P. Myllynen Cadmium inhibits ABCG2 transporter function in BeWo choriocarcinoma cells and MCF-7 cells overexpressing ABCG2 Placenta 33 10 Oct. 2012 859 865
22. P. Huuskonen, P. Myllynen, M. Storvik, and M. Pasanen The effects of aflatoxin B1 on transporters and steroid metabolizing enzymes in JEG-3 cells Toxicol. Lett. 218 3 Apr. 2013 200 206
23. T. Mose, L. Mathiesen, V. Karttunen, J.K.S. Nielsen, E. Sieppi, M. Kummu, T. a Mørck, K. Myöhänen, H. Partanen, K. Vähäkangas, L.E. Knudsen, and P. Myllynen Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris Placenta 33 5 May 2012 433 439
24. K.B. Gützkow, L.S. Haug, C. Thomsen, A. Sabaredzovic, G. Becher, and G. Brunborg Placental transfer of perfluorinated compounds is selective-a Norwegian mother and Child sub-cohort study Int. J. Hyg. Environ. Health 215 2 Feb. 2012 216 219
25. K. Inoue, F. Okada, R. Ito, S. Kato, S. Sasaki, S. Nakajima, A. Uno, Y. Saijo, F. Sata, Y. Yoshimura, R. Kishi, and H. Nakazawa Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy Environ. Health Perspect. 112 11 Apr. 2004 1204 1207
26. O. Midasch, H. Drexler, N. Hart, M.W. Beckmann, and J. Angerer Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study Int. Arch. Occup. Environ. Health 80 7 Jul. 2007 643 648
27. R. Monroy, K. Morrison, K. Teo, S. Atkinson, C. Kubwabo, B. Stewart, and W.G. Foster Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples Environ. Res. 108 1 Sep. 2008 56 62
28. J.R. Hutson, F. Garcia-Bournissen, a Davis, and G. Koren The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs Clin. Pharmacol. Ther. 90 1 Jul. 2011 67 76
29. A.E. van Herwaarden, E. Wagenaar, B. Karnekamp, G. Merino, J.W. Jonker, and A.H. Schinkel Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk Carcinogenesis 27 1 Jan. 2006 123 130
30. J.W. Jonker, G. Merino, S. Musters, A.E. van Herwaarden, E. Bolscher, E. Wagenaar, E. Mesman, T.C. Dale, and A.H. Schinkel The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk Nat. Med. 11 2 Feb. 2005 127 129
31. H. Sarankó, H. Tordai, Á. Telbisz, C. Özvegy-Laczka, G. Erdos, B. Sarkadi, and T. Hegedus Effects of the gout-causing Q141K polymorphism and a CFTR ΔF508 mimicking mutation on the processing and stability of the ABCG2 protein Biochem. Biophys. Res. Commun. 437 1 Jul. 2013 140 145
32. I. Cascorbi Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs Pharmacol. Ther. 112 2006 457 473
33. S. Llop, K. Engström, F. Ballester, E. Franforte, A. Alhamdow, F. Pisa, J.S. Tratnik, D. Mazej, M. Murcia, M. Rebagliato, M. Bustamante, J. Sunyer, A. Sofianou-Katsoulis, A. Prasouli, E. Antonopoulou, I. Antoniadou, S. Nakou, F. Barbone, M. Horvat, and K. Broberg Polymorphisms in ABC transporter genes and concentrations of mercury in newborns - evidence from two Mediterranean birth cohorts PLoS One 9 5 Jan. 2014 e97172
34. B.J. Apelberg, F.R. Witter, J.B. Herbstman, A.M. Calafat, R.U. Halden, L.L. Needham, and L.R. Goldman Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth Environ. Health Perspect. 115 11 Nov. 2007 1670 1676
35. K. Steenland, S. Tinker, S. Frisbee, A. Ducatman, and V. Vaccarino Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant Am. J. Epidemiol. 170 10 Nov. 2009 1268 1278
36. C.R. Stein, D. a Savitz, and M. Dougan Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome Am. J. Epidemiol. 170 7 Oct. 2009 837 846